Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Ticagrelor With Low-dose Aspirin Versus Regular Aspirin in Patients With Acute Coronary Syndrome at High-risk for Ischemia After Percutaneous Coronary Intervention: A Randomized Controlled Study

NCT04240834 is registered in ClinicalTrials.gov with Fu Wai Hospital, Beijing, China as lead sponsor.

NCT NCT04240834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Ticagrelor With Low-dose Aspirin Versus Regular Aspirin in Patients With Acute Coronary Syndrome at High-risk for Ischemia After Percutaneous Coronary Intervention: A Randomized Controlled Study
Lead sponsor
Fu Wai Hospital, Beijing, China
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2021
Completion date
December 31, 2026
Enrollment
1,220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, interventional cardiology